WE investigated the influence of 2-chlorodeoxyadenosine (2-CdA) in combination with tumour necrosis factor-(TNF) or its mutein VI, which differs from the native molecule by N-terminal amino acid composition, on the survival time of mice inoculated with leukaemia L1210 or P388. Groups of mice with leukaemia L1210 and P388 receiving 2-CdA combined with TNF had shorter survival times than animals treated with these agents separately. In contrast, the administration of 2-CdA in conjunction with mutein VI, prolonged the survival of mice inoculated with these leukaemias as compared with animals receiving these agents separately. The results of the present study emphasize the importance of the biological activity of the TNFu molecule N-terminus.
Introduction
The combination of cytokines and cytotoxic drugs offers a new approach to increasing the therapeutic effect in the treatment of neoplastic diseases. There are many possible levels of interactions between these two groups of antineoplastic agents: cellular drug uptake, drug target enzymes, drug metabolizing enzymes.
2-Chlorodeoxyadenosine (2-CdA) is a new antineoplastic drug belonging to the purine analogues, which is especially active in lymphoproliferative disorders. Tumour necrosis factor-cz (TNF0t), a multimodal cytokine, has a wellknown antineoplastic activity. Muteins at a dose 400 btg/kg significantly prolonged the survival time of mice with leukemia P388 (Table  2 ).
The combination of 2-CdA and TNF shortened the survival time of animals in all treated groups. In contrast, mice receiving 2-CdA and mutein VI lived for a significantly longer time than did the animals treated with these agents separately (Tables 1 and 2 ).
Discussion
The interactions between cytokines and antineoplastic drugs are very complex. Cytokines can modulate the metabolism of the drug, the expression of adhesion receptors on tumour cells and gene expression. 7 Cytokines also have a great influence on the host's immune system.
TNF is a polypeptide mediator of inflammation and cellular immune response. It also takes part in the induction of antineoplastic activity of the organism. The mechanism of TNF action is still unclear. Numerous different effects of this cytokine may be explained by both structural and functional heterogeneity of TNF receptors and by a diversification of post-receptor signal transduction pathways. 8 Although two cell surface receptors for TNF, p75 and p55, have been identified recently, the amino acid residues necessary for the biological activity of TNF are still not known. Klysik The mechanism of action of 2-CdA is still unclear, but it may be related to the activation of apoptosis.
12 Apoptosis (programmed cell death) represents a mechanism of cell removal in embryonic development and in controlling cell populations. Defects of this process may be involved in the production of neoplasms. Apoptosis may be induced by many factors, one of them being TNF. 13'14 TNF-activated protein kinase C appears to be involved in the induction of the c-jun, proto-oncogene which seems to be involved in apoptosis.
4--Induction of c-jun transcription is also observed in the treatment of myeloid leukaemia cells with new purine analogues, which have also been shown to induce apoptosis.
